CM
NARI

Castleark Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Castleark Management’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-82,190
Closed -$7.67M – 371
2021
Q2 		$7.67M Buy
82,190
+45,670
+125% +$4.43M 0.26% 107
2021
Q1 		$3.91M Buy
+36,520
New +$3.79M 0.14% 151

Other funds holding NARI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Castleark Management's NARI Position: Q3 2021 in Review

Castleark Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2021, closing a stake of 82,190 shares — an estimated $7.67M sold.

Castleark Management first reported a position in NARI in Q1 2021 and held it in 2 quarters. The position peaked at $7.67M in Q2 2021. 182 funds tracked by Wall St. Rank hold NARI as of Q3 2021.

  • Castleark Management reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Castleark Management sold 82,190 Inari Medical, Inc. Common Stock shares in Q3 2021, an estimated $7.67M.
  • Castleark Management first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Castleark Management's Inari Medical, Inc. Common Stock position peaked at $7.67M in Q2 2021.
  • 182 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2021.

Based on Castleark Management's 13F filing for Q3 2021, filed 12 Nov 2021.